Coordinated Increased Expression of Cyclooxygenase2 and Nuclear Factor 𝜅B Is a Steady Feature of Urinary Bladder Carcinogenesis

Table 1

Clinical profile of the patients. (Figures in parentheses indicate percentages within histological types.)

Clinicopathologic parameters	N% (140p.)
Gender
Male	94 (67%)
Female	46 (33%)
Age	23–90 (70±10)
Normal cases	29 (20.7%)
Grade
GI	27 (24.5%)
GII	30 (27%)
GIII	54 (48.5%)
T stage
Ta	40 (36%)
T1	30 (27%)
T2	26 (23.4%)
T3	9 (8.1%)
T4	6 (5.4%)